Current status on marine products with reversal effect on cancer multidrug resistance

Author(s): Abraham I, El Sayed K, Chen ZS, Guo H

Abstract

The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR) is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp), ABCC1/multidrug resistance protein 1 (MRP1) and ABCG2/breast cancer resistance protein (BCRP). These transporters are part of the ATP-binding cassette (ABC) superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be blocked by various drugs such as verapamil (calcium channel blocker) and cyclosporin A (immunosuppressive agent), etc. These compounds are called MDR modulators or reversals. This review highlights several marine natural products with reversal effect on multidrug resistance in cancer, including agosterol A, ecteinascidin 743, sipholane triterpenoids, bryostatin 1, and welwitindolinones.

Similar Articles

Producing drugs from marine sponges

Author(s): Belarbi el H, Contreras Gómez A, Chisti Y, García Camacho F, Molina Grima E

Marine sponges as pharmacy

Author(s): Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH

Anti-biofilm compounds derived from marine sponges

Author(s): Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, et al.

Biogeography of sponge chemical ecology: comparisons of tropical and temperate defenses

Author(s): Becerro MA, Thacker RW, Turon X, Uriz MJ, Paul VJ

Porifera: Sponges

Author(s): Lavrov D

Drug development from marine natural products

Author(s): Molinski TF, Dalisay DS, Lievens SL, Saludes JP

Marine natural products as anticancer drugs

Author(s): Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH

Approaches to identify, clone, and express symbiont bioactive metabolite genes

Author(s): Hildebrand M, Waggoner LE, Lim GE, Sharp KH, Ridley CP, et al.

The value of natural products to future pharmaceutical discovery

Author(s): Baker DD, Chu M, Oza U, Rajgarhia V

Antiviral lead compounds from marine sponges

Author(s): Sagar S, Kaur M, Minneman KP

Current status on natural products with antitumor activity from Brazilian marine sponges

Author(s): Frota MJ, Silva RB, Mothes B, Henriques AT, Moreira JC

Marine natural products

Author(s): Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR

Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp

Author(s): Longeon A, Copp BR, Quévrain E, Roué M, Kientz B, et al.

Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium

Author(s): Berrué F, McCulloch MW, Boland P, Hart S, Harper MK, et al.

The odyssey of marine pharmaceuticals: a current pipeline perspective

Author(s): Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, et al.

Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra

Author(s): Guzii AG, Makarieva TN, Denisenko VA, Dmitrenok PS, Kuzmich AS, et al.

The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis

Author(s): Rothmeier AS, Schneiders UM, Wiedmann RM, Ischenko I, Bruns CJ, et al.

New lysophosphatidylcholines and monoglycerides from the marine sponge Stelletta sp

Author(s): Zhao Q, Mansoor TA, Hong J, Lee CO, Im KS, et al.